NPR's Noah Adams is talking to Tess Vigeland of Marketplace about the decision by giant pharmaceutical firm Merck to pull its popular arthritis drug Vioxx from the world market. New data has emerged that shows an increased risk of heart attack and stroke among users of the drug.
Copyright 2004 NPR